Mannkind Corporation (mnkd) Ceo Michael Castagna On Q3 2020 Results

MannKind Corporation (NASDAQ:MNKD) Q3 2020 Results Conference Call November 04, 2020 05:00 AM ET Company Participants Michael Castagna - CEO Steven Binder - CFO Conference Call Participants Brandon Fo


Heineken Is Leveraged To Growth Markets And Has Above-average Margin Leverage Potential (otcmkts:heiny)

Heineken has seen a significant hit to volumes during COVID-19, as key operating areas in Latin America, Africa, and Asia have been hit by production, distribution, and retail difficulties.


Mannkind Corporation’s (mnkd) Ceo Michael Castagna On Q2 2020 Results

MannKind Corporation (NASDAQ:MNKD) Q2 2020 Earnings Conference Call August 5, 2020 5:00 PM ET Company Participants Michael Castagna - Chief Executive Officer Steve Binder - Chief Financial Officer Con


Becle: World’s Largest Tequila Producer At Stretched Valuations (otcmkts:bcclf)

Becle is one of the oldest companies in Mexico and the largest tequila producer in the world with 24.4% of the global tequila market.


Heineken N.v.: The Invest And Forget Thesis (otcmkts:heiny)

Heineken has shown stable EPS and dividend increases over the years. Investments into emerging markets present the next areas of growth. Biggest question is how



Heineken is trading for 25% less than its February 2020 highs on the back of short-term headwinds brought by Covid-19 pandemic. The business model is outstandin


Recent Purchase: Pepsico

I recently added to my PepsiCo position at $108.15. Shares were yielding nearly 3.8% at the time. This price represents a sub-20x ttm P/E multiple and a ~18.5x


Remy Cointreau: Buying The Coronavirus Correction

Remy Cointreau has lost nearly a third of its value in recent months. This has coincided with a sharp drop-off in Asian sales, which was primarily linked to the


Mannkind Corporation (mnkd) Ceo Michael Castagna On Q3 2019 Results

MannKind Corporation (NASDAQ:MNKD) Q3 2019 Earnings Conference Call November 6, 2019 09:00 ET Company Participants Michael Castagna - CEO Steven Binder - CFO Co


Krystal Biotech: Kb-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease

Krystal Biotech is currently developing KB-103, an off-the-shelf easily applicable gene therapy for rare congenital skin diseases. If approved, KB-103 will be m

Social Connections